
BRIDGE-PMR (rituximab in PMR) routine care extension to 52w
(in #PMRGCAJC one big qu asked was ?sustained benefit)
sustained benefit (RR 2.5 GC-free remission)
steroid-sparing (PNL 1.6g v 2.3g)
& ritux ?cheap enough now
but COVID calculus difficult
POS0269 #EULAR2022 @RheumNow https://t.co/Ln2ArclKO8 https://t.co/OtCwdjIPeL
Links:
The Lancet Rheumatology on Twitter: "NEW RESEARCH—Efficacy of #rituximab i…
https://twitter.com/TheLancetRheum/status/1438062358434308096
04-06-2022